NSCLC | Consensus or Controversy? The Integration of Novel Therapies into the Interdisciplinary Management of Non-Small Cell Lung Cancer with CNS Metastases

published 1 month ago by Dr Neil Love

Proceedings from a CME symposium held during the 24th Annual Meeting and Education Day of the Society for Neuro-Oncology. Featuring perspectives from moderator Dr Matthew Gubens and faculty members Drs Manmeet S Ahluwalia, Daniel Gomez and Gregory J Riely: Prevalence and Clinical Significance of Central Nervous System (CNS) Involvement in Non-Small Cell Lung Cancer (NSCLC); Indications for Various Local Treatment Modalities — Dr Gomez (00:00) Optimal Management of Brain Metastases in Oncogene-Driven NSCLC — Dr Riely (9:23) Management of Leptomeningeal Metastases in NSCLC with a Targetable Tumor Mutation; Role of Immune Checkpoint Inhibition in the Treatment of CNS Disease Stemming from NSCLC — Dr Ahluwalia (19:59) CME information and select publications

more episodes from Research To Practice | Oncology Videos